Galectin Therapeutics Inc (GALT)
2.78
+0.06
(+2.21%)
USD |
NASDAQ |
Nov 22, 16:00
2.77
-0.01
(-0.36%)
After-Hours: 20:00
Galectin Therapeutics Max Drawdown (5Y): 88.76% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 88.76% |
| September 30, 2024 | 88.76% |
| August 31, 2024 | 88.76% |
| July 31, 2024 | 88.76% |
| June 30, 2024 | 88.76% |
| May 31, 2024 | 88.76% |
| April 30, 2024 | 88.76% |
| March 31, 2024 | 88.76% |
| February 29, 2024 | 88.76% |
| January 31, 2024 | 88.76% |
| December 31, 2023 | 88.76% |
| November 30, 2023 | 88.76% |
| October 31, 2023 | 88.76% |
| September 30, 2023 | 88.76% |
| August 31, 2023 | 88.76% |
| July 31, 2023 | 88.76% |
| June 30, 2023 | 88.76% |
| May 31, 2023 | 88.76% |
| April 30, 2023 | 88.76% |
| March 31, 2023 | 88.76% |
| February 28, 2023 | 88.76% |
| January 31, 2023 | 88.76% |
| December 31, 2022 | 88.76% |
| November 30, 2022 | 91.58% |
| October 31, 2022 | 91.58% |
| Date | Value |
|---|---|
| September 30, 2022 | 91.58% |
| August 31, 2022 | 91.58% |
| July 31, 2022 | 91.58% |
| June 30, 2022 | 91.58% |
| May 31, 2022 | 91.58% |
| April 30, 2022 | 91.58% |
| March 31, 2022 | 91.58% |
| February 28, 2022 | 91.58% |
| January 31, 2022 | 94.32% |
| December 31, 2021 | 94.81% |
| November 30, 2021 | 95.25% |
| October 31, 2021 | 97.21% |
| September 30, 2021 | 97.21% |
| August 31, 2021 | 97.21% |
| July 31, 2021 | 97.21% |
| June 30, 2021 | 97.21% |
| May 31, 2021 | 97.21% |
| April 30, 2021 | 97.21% |
| March 31, 2021 | 97.21% |
| February 28, 2021 | 97.21% |
| January 31, 2021 | 97.21% |
| December 31, 2020 | 97.21% |
| November 30, 2020 | 97.21% |
| October 31, 2020 | 97.21% |
| September 30, 2020 | 97.21% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
88.76%
Minimum
Dec 2022
97.21%
Maximum
Nov 2019
92.91%
Average
91.58%
Median
Feb 2022
Max Drawdown (5Y) Benchmarks
| Microbot Medical Inc | 99.80% |
| Alaunos Therapeutics Inc | 99.76% |
| SELLAS Life Sciences Group Inc | 100.00% |
| Oragenics Inc | 99.67% |
| Anavex Life Sciences Corp | 88.25% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -19.51 |
| Beta (5Y) | 0.6235 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 79.60% |
| Historical Sharpe Ratio (5Y) | -0.144 |
| Historical Sortino (5Y) | -0.4379 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 22.90% |